Publications by authors named "Shiro Ibe"

Claim this Profile
E
Evaluation of the Geenius HIV 1/2 confirmatory assay for HIV-2 samples isolated in Japan.
Urara Shigemi, Yoshimi Yamamura, Masakazu Matsuda, Reiko Okazaki, Mai Kubota, Shiro Ibe

J Clin Virol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical usefulness of multiplex PCR-lateral flow for the diagnosis of orthopedic-related infections.
Yojiro Minegishi, Katsufumi Uchiyama, Keizo Sakurai, Shiro Ibe, Hiromi Kanda

Mod Rheumatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana.
Nicholas Israel Nii-Trebi, James Ashun Mensah Brandful, Shiro Ibe, Wataru Sugiura, Jacob Samson Barnor

J Med Microbiol· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological characteristics of hepatitis B genotype G/A2 recombination virus in Japan.
Yuji Tsuzuki, Tsunamasa Watanabe, Etsuko Iio, Seiichiro Fujisaki, Shiro Ibe

Hepatol Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 CRF01_AE and Subtype B Transmission Networks Crossover: A New AE/B Recombinant Identified in Japan.
Masumi Hosaka, Seiichiro Fujisaki, Aki Masakane, Junko Hattori, Teiichiro Shiino, Shiro Ibe

AIDS Res Hum Retroviruses· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Japanese external quality assessment program to standardize HIV-1 drug-resistance testing (JEQS2010 program) using in vitro transcribed RNA as reference material.
Shigeru Yoshida, Junko Hattori, Masakazu Matsuda, Kiyomi Okada, Yukumasa Kazuyama, Shiro Ibe

AIDS Res Hum Retroviruses· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana.
Nicholas I Nii-Trebi, Shiro Ibe, Jacob S Barnor, Koichi Ishikawa, James A M Brandful

PLoS One· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.
Fatemeh Jahanbakhsh, Junko Hattori, Masakazu Matsuda, Shiro Ibe, Seyed-Hamid R Monavari

PLoS One· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The carboxyl-terminus of human immunodeficiency virus type 2 circulating recombinant form 01_AB capsid protein affects sensitivity to human TRIM5α.
Tadashi Miyamoto, Emi E Nakayama, Masaru Yokoyama, Shiro Ibe, Shunpei Takehara

PLoS One· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular epidemiology of HIV type 1 infection in Iran: genomic evidence of CRF35_AD predominance and CRF01_AE infection among individuals associated with injection drug use.
Fatemeh Jahanbakhsh, Shiro Ibe, Junko Hattori, Seyed Hamid Reza Monavari, Masakazu Matsuda

AIDS Res Hum Retroviruses· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular HIV-1 DNA levels in patients receiving antiretroviral therapy strongly correlate with therapy initiation timing but not with therapy duration.
Dai Watanabe, Shiro Ibe, Tomoko Uehira, Rumi Minami, Atsushi Sasakawa

BMC Infect Dis· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outbreak of infections by hepatitis B virus genotype A and transmission of genetic drug resistance in patients coinfected with HIV-1 in Japan.
Seiichiro Fujisaki, Yoshiyuki Yokomaku, Teiichiro Shiino, Tomohiko Koibuchi, Junko Hattori, Shiro Ibe

J Clin Microbiol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical significance of HIV reverse-transcriptase inhibitor-resistance mutations.
Shiro Ibe, Wataru Sugiura

Future Microbiol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: nationwide surveillance from 2003 to 2008 in Japan.
Junko Hattori, Teiichiro Shiino, Hiroyuki Gatanaga, Shigeru Yoshida, Dai Watanabe, Shiro Ibe

Antiviral Res· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-2 CRF01_AB: first circulating recombinant form of HIV-2.
Shiro Ibe, Yoshiyuki Yokomaku, Teiichiro Shiino, Rie Tanaka, Junko Hattori

J Acquir Immune Defic Syndr· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Current topics on drug-resistant HIV in Japan].
Shiro Ibe, Wataru Sugiura

Nihon Rinsho· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An 11-Year Surveillance of HIV Type 1 Subtypes in Nagoya, Japan.
Seiichiro Fujisaki, Shiro Ibe, Junko Hattori, Urara Shigemi, Saeko Fujisaki

AIDS Res Hum Retroviruses· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of near full-length genomic sequences of drug-resistant HIV-1 spreading among therapy-naïve individuals in Nagoya, Japan: amino acid mutations associated with viral replication activity.
Shiro Ibe, Urara Shigemi, Kaori Sawaki, Seiichiro Fujisaki, Junko Hattori

AIDS Res Hum Retroviruses· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trend of drug-resistant HIV type 1 emergence among therapy-naive patients in Nagoya, Japan: an 8-year surveillance from 1999 to 2006.
Shiro Ibe, Junko Hattori, Seiichiro Fujisaki, Urara Shigemi, Saeko Fujisaki

AIDS Res Hum Retroviruses· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No observable correlation between central nervous system side effects and EFV plasma concentrations in Japanese HIV type 1-infected patients treated with EFV containing HAART.
Masaaki Takahashi, Shiro Ibe, Yuichi Kudaka, Naoya Okumura, Atsushi Hirano

AIDS Res Hum Retroviruses· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-resistant HIV-1 prevalence in patients newly diagnosed with HIV/AIDS in Japan.
Hiroyuki Gatanaga, Shiro Ibe, Masakazu Matsuda, Shigeru Yoshida, Tsukasa Asagi

Antiviral Res· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Performance and quality assurance of genotypic drug-resistance testing for human immunodeficiency virus type 1 in Japan.
Seiichiro Fujisaki, Saeko Fujisaki, Shiro Ibe, Tsukasa Asagi, Toshihiro Itoh

Jpn J Infect Dis· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative SNP-detection method for estimating HIV-1 replicative fitness: application to protease inhibitor-resistant viruses.
Shiro Ibe, Saeko Fujisaki, Seiichiro Fujisaki, Takayuki Morishita, Tsuguhiro Kaneda

Microbiol Immunol· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Delayed HIV-1 infection of CD4+ T lymphocytes from therapy-naïve patients demonstrated by quantification of HIV-1 DNA copy numbers.
Kaoru Wada, Hiromi Nagai, Tomoko Hagiwara, Shiro Ibe, Makoto Utsumi

Microbiol Immunol· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cloning of a novel gene for quinolone resistance from a transferable plasmid in Shigella flexneri 2b.
Mami Hata, Masahiro Suzuki, Masakado Matsumoto, Masao Takahashi, Katsuhiko Sato, Shiro Ibe

Antimicrob Agents Chemother· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis